These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 37277184)
1. A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid (CB Yang L; Zhu X; Finlay DB; Green H; Glass M; Duffull SB Br J Pharmacol; 2023 Oct; 180(20):2661-2676. PubMed ID: 37277184 [TBL] [Abstract][Full Text] [Related]
2. Insight into the mechanism of action of ORG27569 at the cannabinoid type one receptor utilising a unified mathematical model. Green HM; Yang L; Zhu X; Finlay DB; Duffull SB; Glass M Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5105-5118. PubMed ID: 38227196 [TBL] [Abstract][Full Text] [Related]
4. Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation. Ahn KH; Mahmoud MM; Kendall DA J Biol Chem; 2012 Apr; 287(15):12070-82. PubMed ID: 22343625 [TBL] [Abstract][Full Text] [Related]
5. Structure of an allosteric modulator bound to the CB1 cannabinoid receptor. Shao Z; Yan W; Chapman K; Ramesh K; Ferrell AJ; Yin J; Wang X; Xu Q; Rosenbaum DM Nat Chem Biol; 2019 Dec; 15(12):1199-1205. PubMed ID: 31659318 [TBL] [Abstract][Full Text] [Related]
6. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors. Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240 [TBL] [Abstract][Full Text] [Related]
7. Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling. Shore DM; Baillie GL; Hurst DH; Navas F; Seltzman HH; Marcu JP; Abood ME; Ross RA; Reggio PH J Biol Chem; 2014 Feb; 289(9):5828-45. PubMed ID: 24366865 [TBL] [Abstract][Full Text] [Related]
16. A potential role for cannabinoid receptors in the therapeutic action of fenofibrate. Priestley RS; Nickolls SA; Alexander SP; Kendall DA FASEB J; 2015 Apr; 29(4):1446-55. PubMed ID: 25550466 [TBL] [Abstract][Full Text] [Related]
17. Assessing Allosteric Modulation of CB Scott CE; Kendall DA Methods Enzymol; 2017; 593():317-342. PubMed ID: 28750809 [TBL] [Abstract][Full Text] [Related]
18. Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs. Obi P; Natesan S J Med Chem; 2022 Sep; 65(18):12240-12255. PubMed ID: 36066412 [TBL] [Abstract][Full Text] [Related]
19. Benzophenanthridine alkaloid, piperonyl butoxide and (S)-methoprene action at the cannabinoid-1 receptor (CB1-receptor) pathway of mouse brain: Interference with [(3)H]CP55940 and [(3)H]SR141716A binding and modification of WIN55212-2-dependent inhibition of synaptosomal l-glutamate release. Dhopeshwarkar AS; Nicholson RA Eur J Pharmacol; 2014 Jan; 723():431-41. PubMed ID: 24211785 [TBL] [Abstract][Full Text] [Related]
20. Effects of the cannabinoid CB₁ receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats. Jing L; Qiu Y; Zhang Y; Li JX Drug Alcohol Depend; 2014 Oct; 143():251-6. PubMed ID: 25169627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]